Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Minoxidil improves hair loss in breast cancer patients on CDK4/6-inhibitor therapy.

Low-dose oral minoxidil is safe for hair loss, with no link between side effects and patient demographics.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Poliosis is common in severe alopecia areata but doesn't significantly affect overall prognosis.

Women with lichen planopilaris and frontal fibrosing alopecia often have other health issues like hypothyroidism and lupus.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Topical dapsone gel reduced flare-ups in folliculitis decalvans without side effects.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Degenerative changes in the lower cervical spine are common in patients with abnormal scalp sensations, with some improvement seen using pain medication and physical therapy.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Alopecia totalis/universalis is linked to more autoimmune diseases than patchy alopecia areata.

Excimer laser therapy may help improve scarring alopecia symptoms and hair appearance.

Finasteride may lower depression risk in younger men with hair loss but increase it in older men with prostate issues.

Combining concentrated growth factor with intense pulsed light is more effective and safer for sensitive skin than using intense pulsed light alone.

Androgenetic alopecia is not linked to higher heart disease risk.

Frontal fibrosing alopecia has a higher remission rate than lichen planopilaris.

The treatment effectively improved hair growth and was well tolerated in most men.

Digital care for hair loss significantly improves men's quality of life.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Lower postoperative hematocrit levels increase the risk of death within 28 days after coronary artery bypass surgery.

Statins do not help improve alopecia areata.

Statins do not help improve alopecia areata.

Severe COVID-19 increases the risk of hair loss.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.